Figure 2

Antibody levels in study patients (A: anti-Eno and B: anti-Fba1). Patients with candidemia, Candida colonization, bacteremia, invasive aspergillosis and healthy controls were evaluated for the presence of anti-Eno and anti-Fba1 antibodies. The levels of anti-Eno and anti-Fba1 in patients with candidemia were higher than control groups. Boxes indicate interquartile ranges (25–75th percentiles). Horizontal bars in bold indicate the median value in each group. Whiskers extend to 1.5 times the interquartile range. ^* P < 0.001, for the comparison with the patients with candidemia; ^** P < 0.001, for the comparison with the patients with candidemia.